Evidence map›Paper›PMID 39639169›Full record

ArticleNature methods2025

The dynamics of hematopoiesis over the human lifespan.

Hojun Li, Parker Côté, Michael Kuoch, Jideofor Ezike, Katie Frenis, Anton Afanassiev, Laura Greenstreet, Mayuri Tanaka-Yano, Giuseppe Tarantino, Stephen Zhang and 18 more

Abstract read
In one paragraph

Article in Nature methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. The endothelial scavenger receptorbioRxiv : the preprint server for biology · 2026
    Article
  8. Article
  9. Improving lymphopoiesis in aged bone marrow.Current opinion in hematology · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. ATP2B1 expression identifies human hematopoietic stem cells with superior repopulation and self-renewal.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Hojun LiDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. hojun@health.ucsd.edu.ORCID http://orcid.org/0000-0002-8129-0390
Parker Côté *Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Michael Kuoch *Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-1229-7879
Jideofor EzikeComputational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, MA, USA.
Katie FrenisDivision of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0003-4103-0882
Anton AfanassievDepartment of Mathematics, University of British Columbia, Vancouver, British Columbia, Canada.
Laura GreenstreetDepartment of Mathematics, University of British Columbia, Vancouver, British Columbia, Canada.
Mayuri Tanaka-YanoDivision of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0001-6309-3273
Giuseppe TarantinoDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-6078-6856
Stephen ZhangDepartment of Mathematics, University of British Columbia, Vancouver, British Columbia, Canada.
Jennifer WhangboDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Vincent L ButtyBarbara K. Ostrom Bioinformatics Facility, Integrated Genomics and Bioinformatics Core of the Koch Institute, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-1173-2429
Enrico MoisoKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-4405-8357
Marcelo FalchettiDepartments of Microbiology, Immunology and Parasitology, Federal University of Santa Catarina, Florianopolis, Brazil.ORCID http://orcid.org/0000-0002-9438-680X
Kate LuKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Guinevere G ConnellyKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-4861-8574
Vivian MorrisDivision of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
Dahai WangDivision of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
Antonia F ChenHarvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-2040-8188
Giada BianchiHarvard Medical School, Boston, MA, USA.
George Q DaleyDivision of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-6346-5919
Salil GargKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
David LiuHarvard Medical School, Boston, MA, USA.
Stella T ChouDivision of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Aviv RegevDivision of Hematology/Oncology, Rady Children's Hospital, San Diego, CA, USA.ORCID http://orcid.org/0000-0003-3293-3158
Edroaldo Lummertz da RochaDepartments of Microbiology, Immunology and Parasitology, Federal University of Santa Catarina, Florianopolis, Brazil.ORCID http://orcid.org/0000-0003-0537-4223
Geoffrey SchiebingerDepartment of Mathematics, University of British Columbia, Vancouver, British Columbia, Canada.ORCID http://orcid.org/0000-0002-8290-7997
R Grant RoweDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. grant_rowe@dfci.harvard.edu.ORCID http://orcid.org/0000-0003-3620-2950

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Jacqueline A. Lees · 1985 to 2026
$93.9M
Improving transfusion therapy for patients with sickle cell disease with pluripotent stem cell-derived red cellsU01HL134696 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI CHOU, STELLA T · 2016 to 2022
$8.3M
Graduate Training in Computational and Systems BiologyT32GM087237 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BURGE, CHRISTOPHER B · 2009 to 2023
$4.6M
Modeling genetic modifiers of hematopoiesis with induced pluripotent stem cellsR01DK100854 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI CHOU, STELLA T · 2014 to 2018
$2.0M
Control of hematopoietic maturation by Lin28b/let-7R01DK134515 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI Robert Grant Rowe · 2022 to 2026
$1.8M
Regulating proliferation and differentiation of erythroid progenitorsK08DK123414 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LI, HOJUN · 2020 to 2024
$828k
Age-specific differentiation of multipotent progenitorsR03DK126729 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI ROWE, ROBERT GRANT · 2022 to 2023
$266k
NCI NIH HHS P30 CA014051NHLBI NIH HHS U01 HL134696NIDDK NIH HHS K08 DK123414NIDDK NIH HHS R01 DK100854NIDDK NIH HHS R01 DK134515NIDDK NIH HHS R03 DK126729NIGMS NIH HHS T32 GM087237U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) U01HL134696U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) K08DK123414U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) R01DK134515U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) R03DK126729U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (National Cancer Institute Division of Cancer Epidemiology and Genetics) P30CA14051
6 · The paper itself

Abstract

Over a lifetime, hematopoietic stem cells (HSCs) adjust their lineage output to support age-aligned physiology. In model organisms, stereotypic waves of hematopoiesis have been observed corresponding to defined age-biased HSC hallmarks. However, how the properties of hematopoietic stem and progenitor cells change over the human lifespan remains unclear. To address this gap, we profiled individual transcriptome states of human hematopoietic stem and progenitor cells spanning gestation, maturation and aging. Here we define the gene expression networks dictating age-specific differentiation of HSCs and the dynamics of fate decisions and lineage priming throughout life. We additionally identifiy and functionally validate a fetal-specific HSC state with robust engraftment and multilineage capacity. Furthermore, we observe that classification of acute myeloid leukemia against defined transcriptional age states demonstrates that utilization of early life transcriptional programs associates with poor prognosis. Overall, we provide a disease-relevant framework for heterochronic orientation of stem cell ontogeny along the real time axis of the human lifespan.

Indexed as

AgingHematopoiesisHematopoietic Stem CellsLongevityAdultAnimalsCell DifferentiationCell LineageFemaleGene Expression ProfilingHumansLeukemia, Myeloid, AcuteMaleMiceMiddle AgedTranscriptome

Identifiers

PMID39639169
PMCPMC11908799

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.